Technical Analysis for LIVN - LivaNova PLC

Grade Last Price % Change Price Change
grade C 95.85 -2.41% -2.37
LIVN closed down 2.41 percent on Friday, March 22, 2019, on 76 percent of normal volume.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Flat
See historical LIVN trend table...

Date Alert Name Type % Chg
Mar 22 Inside Day Range Contraction 0.00%
Mar 21 20 DMA Support Bullish -2.41%
Mar 20 20 DMA Support Bullish 0.29%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.29%
Mar 19 Crossed Above 20 DMA Bullish 0.59%
Mar 18 Fell Below 20 DMA Bearish 0.50%
Mar 18 MACD Bullish Signal Line Cross Bullish 0.50%
Mar 15 Shooting Star Candlestick Bearish 0.01%
Mar 15 Lizard Bearish Bearish Day Trade Setup 0.01%
Mar 15 20 DMA Support Bullish 0.01%

Older signals for LIVN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Sand Holdco PLC, through its subsidiaries, Sand Holdco PLC Cardiac Surgery, Cardiac Rhythm Management, and Neuromodulation, provides healthcare equipment. The company was incorporated in 2015 and is based in London, United Kingdom. Sand Holdco PLC operates as a subsidiary of Sorin SpA.
Medicine Neuroscience Ion Television Nervous System Neuromodulation Neurotechnology Healthcare Equipment
Is LIVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 18 LivaNova Announces Trui Hebbelinck as Chief Human Resources Officer
Mar 15 LivaNova to Present Autonomic Regulation Therapy Findings for Chronic Heart Failure Patients at the American College of Cardiology 68th Annual Scientific Session
Mar 6 Investor Expectations to Drive Momentum within Amarin, PulteGroup, LivaNova, Teva Pharmaceutical Industries, Viad, and Activision Blizzard — Discovering Underlying Factors of Influence
Mar 4 LivaNova to be late with 2018 annual report
Feb 27 LivaNova PLC (LIVN) CEO Damien McDonald on Q4 2018 Results - Earnings Call Transcript
Feb 27 LivaNova PLC (LIVN) Q4 2018 Earnings Conference Call Transcript
Feb 27 LivaNova Q4 top line up 7%
Feb 27 LivaNova PLC 2018 Q4 - Results - Earnings Call Slides
Feb 27 LivaNova PLC beats by $0.02, beats on revenue
Feb 27 LivaNova Reports Fourth Quarter and Full-Year 2018 Results
See more LIVN news...
Indicators
Indicator Value
52 Week High 131.54
52 Week Low 79.96
Average Volume 524,053
200-Day Moving Average 106.1948
50-Day Moving Average 93.3436
20-Day Moving Average 94.8685
10-Day Moving Average 95.689
Average True Range 2.8865
ADX 12.33
+DI 21.6372
-DI 16.9585
Chandelier Exit (Long, 3 ATRs ) 91.9805
Chandelier Exit (Short, 3 ATRs ) 96.9095
Upper Bollinger Band 98.371
Lower Bollinger Band 91.366
Percent B (%b) 0.64
BandWidth 7.383905
MACD Line 0.6178
MACD Signal Line 0.4822
MACD Histogram 0.1356
Fundamentals Value
Market Cap 4.68 Billion
Num Shares 48.9 Million
EPS 0.56
Price-to-Earnings (P/E) Ratio 171.16
Price-to-Sales 2.96
Price-to-Book 1.92
PEG Ratio 1.64
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 99.06
Resistance 3 (R3) 99.27 98.42 98.53
Resistance 2 (R2) 98.42 97.60 98.31 98.35
Resistance 1 (R1) 97.13 97.09 96.71 96.92 98.17
Pivot Point 96.28 96.28 96.06 96.17 96.28
Support 1 (S1) 94.99 95.46 94.57 94.78 93.53
Support 2 (S2) 94.14 94.95 94.03 93.35
Support 3 (S3) 92.85 94.14 93.18
Support 4 (S4) 92.64